home / stock / ckpt / ckpt quote
Last: | $2.18 |
---|---|
Change Percent: | 0.0% |
Open: | $2.13 |
Close: | $2.18 |
High: | $2.35 |
Low: | $2.11 |
Volume: | 712,408 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.18 | $2.13 | $2.18 | $2.35 | $2.11 | 712,408 | 07-04-2024 |
$2.18 | $2.13 | $2.18 | $2.35 | $2.11 | 712,402 | 07-03-2024 |
$2.13 | $2.07 | $2.13 | $2.1499 | $2 | 392,763 | 07-02-2024 |
$2.05 | $2.13 | $2.05 | $2.16 | $2 | 177,321 | 07-01-2024 |
$2.15 | $2.04 | $2.15 | $2.15 | $2.03 | 252,621 | 06-28-2024 |
$2.06 | $2 | $2.06 | $2.08 | $2 | 150,723 | 06-27-2024 |
$2.07 | $2.05 | $2.07 | $2.08 | $1.95 | 338,442 | 06-26-2024 |
$2.09 | $2.15 | $2.09 | $2.19 | $2 | 441,626 | 06-25-2024 |
$2.08 | $1.97 | $2.08 | $2.1 | $1.87 | 718,256 | 06-24-2024 |
$1.8 | $1.91 | $1.8 | $2.04 | $1.8 | 608,861 | 06-21-2024 |
$1.89 | $2 | $1.89 | $2.0055 | $1.85 | 258,556 | 06-20-2024 |
$1.94 | $2.02 | $1.94 | $2.12 | $1.91 | 346,436 | 06-19-2024 |
$1.94 | $2.02 | $1.94 | $2.12 | $1.91 | 346,436 | 06-18-2024 |
$2.03 | $2.11 | $2.03 | $2.185 | $1.96 | 361,934 | 06-17-2024 |
$2.12 | $2.06 | $2.12 | $2.2 | $2.05 | 463,043 | 06-14-2024 |
$2.05 | $2.02 | $2.05 | $2.1 | $2 | 218,148 | 06-13-2024 |
$2.02 | $2.05 | $2.02 | $2.1 | $1.98 | 451,860 | 06-12-2024 |
$1.95 | $1.95 | $1.95 | $2.05 | $1.89 | 326,619 | 06-11-2024 |
$1.94 | $1.88 | $1.94 | $2.03 | $1.85 | 557,494 | 06-10-2024 |
$1.89 | $1.85 | $1.89 | $1.91 | $1.84 | 146,165 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Checkpoint Therapeutics Inc. Company Name:
CKPT Stock Symbol:
NASDAQ Market:
Checkpoint Therapeutics Inc. Website:
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional in...
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has completed the resubmission of its Biologics License Application (“BLA”) t...
WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has reached alignment with the Food and Drug Administration (“FDA”) on its bi...